Andrew Combs - Chief Chemistry Officer at Prelude Therapeutics Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Chemistry Officer
Stock Symbol
PRLD on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Andrew Combs since 12/22/2023

Holdings reported by Andrew Combs for Prelude Therapeutics Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Employee Stock Option (right to buy) 150K Mar 1, 2024 Direct Common Stock

Transactions reported by Andrew Combs for Prelude Therapeutics Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.